Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
October 2015

The FDA has approved flibanserin (Addyi) to treat low or absent libido in women.

ADHD Mortality
In a study in Denmark, attention-deficit/hyperactivity disorder (ADHD) was associated with an increased risk of mortality, especially in patients 18 years and older and in female patients.

Antidepressants, NSAIDs, and the Risk of Intracranial Hemorrhage
In a large, retrospective cohort study, patients who took an antidepressant concomitantly with a nonsteroidal anti-inflammatory drug (NSAID) were more likely to suffer an intracranial hemorrhage than those who took an antidepressant alone.

In Brief
Synthetic Cannabinoids Dangerous and Readily Available; Women with Memory Impairment Worsen More Quickly than Men

Stimulants for Geriatric Depression
As an adjunct to antidepressants, methylphenidate (Ritalin and others) may improve symptoms of depression in elderly patients and accelerate response.

Download a Sample Issue of BTP

A following sample issue of Biological Therapies in Psychiatry is available in .pdf format. These files require Adobe Acrobat© Reader to view. (If you do not currently have the Acrobat Reader, click here to download).

Download a free sample pdf of BTP

One, two and three-year subscriptions are immediately available. Each subscription allows you full online access to current and recent issues, a searchable online database, downloadable audio files, and a printed newsletter that will be mailed to you monthly. You'll receive timely, accurate information at a very reasonable price. A one-year US subscription is only $90.00.